AI boosts skin diagnosis accuracy for GPs in small trial
NCT ID NCT07428941
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether an artificial intelligence (AI) tool could help primary care doctors diagnose skin conditions more accurately. Nine doctors reviewed 30 images of various skin problems, first giving their own diagnosis and then a final diagnosis after seeing the AI's suggestions. The goal was to see if the AI improved diagnostic accuracy and helped doctors decide whether a patient needs a specialist referral.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AI-based medical device (Legit.Health Plus) for computer-aided diagnosis of skin lesions
What this could lead to
If successful, this AI tool could help primary care doctors diagnose skin conditions more accurately and reduce unnecessary specialist referrals.
What could go wrong
This is a small, completed study with only 9 doctors and 30 images, so results may not apply to real-world settings or larger populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLAQUE PSORIASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AI Labs Group S.L.
Bilbao, Basque Country, 48001, Spain